Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) CEO David M. Stack sold 5,058 shares of the company’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $38.99, for a total transaction of $197,211.42. Following the transaction, the chief executive officer now owns 159,107 shares of the company’s […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,047 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $37.87, for a total transaction of $39,649.89. Following the completion of the transaction, the chief operating officer now owns 21,539 shares in […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) insider Roy Winston sold 1,779 shares of Pacira BioSciences stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $38.99, for a total value of $69,363.21. Following the transaction, the insider now owns 43,213 shares of the company’s stock, valued at […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $38.74, for a total transaction of $38,740.00. Following the transaction, the chief operating officer now owns 23,591 shares in the […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) Director Gary W. Pace sold 5,015 shares of the business’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $41.78, for a total value of $209,526.70. Following the completion of the transaction, the director now owns 139,675 shares in the […]